ID   KRC-110
AC   CVCL_E736
SY   KRC 110; KRC110
DR   dbMHC; 48933
DR   ECACC; 94071446
DR   IHW; IHW09359
DR   IPD-IMGT/HLA; 10934
DR   Wikidata; Q54900460
RX   PubMed=9331945;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Native South American; Kaingang.
CC   HLA typing: A*31:01:02,24:02:01; B*51:01:01,15:20; C*03:04:01 (IPD-IMGT/HLA=10934).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
RX   PubMed=9331945; DOI=10.1111/j.1399-0039.1997.tb02866.x;
RA   Parham P., Arnett K.L., Adams E.J., Little A.-M., Tees K., Barber L.D.,
RA   Marsh S.G.E., Ohta T., Markow T.A., Petzl-Erler M.-L.;
RT   "Episodic evolution and turnover of HLA-B in the indigenous human
RT   populations of the Americas.";
RL   Tissue Antigens 50:219-232(1997).
//